The Effect of Darbepoetin Upon Rehabilitation for Colorectal Cancer Surgery
Colorectal Cancer
About this trial
This is an interventional treatment trial for Colorectal Cancer focused on measuring colorectal cancer, erythropoietin, rehabilitation, physical capacity
Eligibility Criteria
Inclusion Criteria: Planned colonic and rectal surgery because of presumed cancer disease in the colon and rectum Exclusion Criteria: Psychiatric disease or dementia Diseases, that renders participation in the study impossible Thromboembolic disease within the last three months Dysregulated hypertension (systolic blood pressure>175 mmHg and/or diastolic blood pressure>105 mmHg) Other diseases or causes that will contraindicate treatment with Darbepoetin Alfa Other diseases or causes that will contraindicate further treatment with Darbepoetin Alfa Patients that preoperatively and/or four days postoperatively have a hemoglobin concentration > 14 g/dl Former cancer disease Disseminated cancer disease Rectal cancer stage T4
Sites / Locations
- Surgical Department, Middelfart Hospital
- Surgical Department, Odense University Hospital
- Surgical Department, Svendborg Hospital
- Surgical Department, Herning Hospital
- Surgical Department, Aarhus University Hospital